INTRODUCTION
Disinfection by-products (DBPs) appear during water treatment when organic matter reacts with the disinfectant. Trihalometanes (THMs) are one of the most abundant classes in chlorinated waters, and Spain has showed in the past high levels compared to Northern Europe. 1 Lifetime exposure to DBPs has been related to bladder cancer, 2, 3 and possibly colorectal cancer 4 in epidemiological studies. However, mechanisms involved in these deleterious effects are not clear.
Some mechanisms of action have been proposed for DBPs from experimental models. Cytotoxicity, defined as an alteration of the cell integrity with or without direct DNA damage, has been shown by some compounds (i.e. chloroform and trichloroacetic acid), probably dependent on the release of oxidative free radicals during liver reductive metabolism through cytochromes. 5, 6 For some brominated compounds, it has been proposed that in vivo bioactivation through gluthatione S transferases (GSTT1) generates carbonyl radicals which could be genotoxic (attach as adducts to DNA). 7 However, these two mechanisms do not completely explain the effects observed when the doses are low and exposure is chronic. In chronic low doses, the toxicants may generate non-mutational changes as a consequence of repetitive cytotoxicity/regeneration cycles that may produce somatic changes in the methylation of DNA in the DNA daughter strands, leading to DNA instability and induction of apoptotic pathways. 8 In mice, the exposure to several trihalometanes and haloacetic acids (the second most abundant DBP in chlorinated waters) reduced global DNA methylation levels. Specifically hypomethylation of some protooncogenes (c-myc and cjun) associated with increased mRNA expression has been documented. The exposed mice had higher than expected rates of kidney and liver tumours. [8] [9] [10] [11] The mechanistic evidence in humans is limited. Epidemiological studies have shown an interaction with polymorphisms of GSTT1 and CYP2E1 for bladder cancer in subjects chronically exposed to THM in drinking water. 12 Furthermore, levels of DNA methylation at some transposons (LINE-1) in granulocytes increased with lifetime THM exposure in controls. 13 To our knowledge, there are no studies exploring THM chronic exposure and changes in genome-wide DNA methylation. In this context, we aim to explore the association between lifetime exposure to THM and DNA methylation levels through an Epigenome Wide Association Study (EWAS).
RESULTS
From the 138 subjects analyzed, the mean age (standard deviation, SD) and sex ratio of study participants was similar between exposure groups (Table 1) . Only 6 subjects in the low exposed group and 10 in the high exposed group were current smokers. Most of the subjects (>70%) had elementary studies or less. The estimated blood cell proportions of CD8T, NK and B lymphocytes were non-statistically different between exposure groups, while the proportion of granulocytes was statistically higher in the less exposed group. Most of the THM exposure was due to brominated THM in the high exposed group, while chloroform predominated in the low exposed group.
The methylation intensities in both Infinium I and II assays showed an expected bimodal distribution when all probes were plotted together, but approximately normal distribution for most of the CpGs when considered individually. From the original 485,577 probes we excluded potentially unreliable probes leaving 252,156 for analyses ( Figure 1 ). Among these, crude mean methylation levels were statistically significant different between exposure groups in 23,302 CpG sites after multiple comparison correction (FDR < 0.05, lambda= 1.207). Using the selectModel command, the variables which best adjusted all the models were age, sex, the first principal component (surrogate variable) and the estimated blood cell proportions. After adjustment for these covariables, 1,840 CpG sites showed different mean methylation levels between exposure groups after FDR correction (FDR < 0.05, lambda= 1.048). Using the observed mean methylation values, 140 CpG sites had an absolute observed deltabeta >0.05 between exposure groups (Supplementary table S1 ). Among them, in 29 CpG sites the covariate adjusted beta coefficient showed differences >0.05 because of THM exposure (absolute expected deltabeta between 0.051 to 0.15) ( Table 2) . A cluster of high exposed subjects was associated with differential methylation of these 29 CpG sites ( Figure 2 ).
For pathway analyses we included all the genes annotated by Illumina to specific CpG sites (intergenomic regions were not included, as they cannot be properly annotated to a contiguous gene). Using GSEA, 96 pathways were enriched using KeGG (p-value of the Family Wise Error Rate, FWER <0.001), and 128 using Reactome (Supplementary tables S2 and S3). Induced networks of the 140 CpG sites showed multiple interrelationships with SOX2 and RB1 pathways ( Figure 3 ) which are respectively an oncogene and a tumor suppressor associated with different classes of cancer, including bladder and colorectal cancer ( Table 2) .
A specific evaluation of the 29 CpG sites with absolute beta coefficients above 0.05 in the adjusted model was also explored. As the pathways were not enriched using this shortlist, a manual PubMed search of the related genes was performed. Other diseases (type 2 diabetes mellitus, Usher syndrome, and non-syndromic cleft lip), and some cell specific pathological and physiological mechanisms (duplications, repair of N-alkylated nucleotides, leukocyte migration) were also found for some of these genes. Differentially methylated regions (Table 3 ) results overlap several genes found on the differentially methylated sites (CEP97, API5, SNORD114-9, SNORD114-11, MYNN and PCDH15).
All the sensitivity analyses provided larger top lists with slightly different variations on the order of the top hits. However, the differentially methylated top hits were preserved independently of the strategy used (normalization, robust modeling or less stringent filtering of probes). We opted to keep the shortest most conservative list.
DISCUSSION
This is the first DNA methylation wide epigenomic study linking chronic THM exposure to changes in human DNA methylation. We found that subjects with an average lifetime THM exposure higher than 85 µg/L showed 29 CpG sites differentially methylated (FDR <0.05 and absolute expected delta beta >0.05) compared to those with less exposure. Some of the genes annotated to these sites are associated with different cancers including bladder and colorectal.
Epidemiological studies have suggested that chronic exposure to DBPs increases bladder cancer risk. 2, 3 Experimental evidence has suggested that the mechanisms behind DBP carcinogenicity may partially be explained by epigenetic alterations that result from chronic cytotoxicity mediated by a mixture between oxidative metabolites release, reductive free radicals, and cell integrity disruption. 5, 32 For non genotoxic compounds, cycles of mitotic regeneration in response to cytotoxicity may produce cumulative epigenetic changes. 8 These cumulative epigenetic changes, and particularly global DNA hypomethylation, may lead to genomic instability and cell apoptosis. 33 In particular, global DNA hypomethylation and hypomethylation of several protooncogenes after exposure to several THM and HAA has been described in rodents,. [8] [9] [10] [11] This specific derepression of protooncogenes may lead to overcome the apoptotic pathways and generate survival of transformed neoplasic cells. 34 In our data, the induced networks and several individual CpG sites, annotated to specific genes, suggest a mechanism related to tumor suppressor release (RB1), or oncogene activation (SOX2) which may explain part of the THM mechanism in humans. Moreover, some of the differentially methylated sites and regions are located in genes related to both or specifically to bladder cancer 16, 20 and colorectal cancer 21, 35 (MYNN, SOX2, RB1, SMAD3) which supports this hypothesis. In addition, KeGG pathways in cancer was ranked 2 in the GSEA analysis (colorectal was ranked 22 and bladder cancer 58, both significant). Using Reactome EGFR signaling in cancer was ranked 45. Other cancer related pathways enriched include p53, MAPK, and PPAR signaling. Other metabolic, immunological and neurodevelopment pathways were also enriched unspecifically using both curated databases.
We used total THM as a DBP exposure proxy and classified subjects into two exposure categories. This was a simplistic approach followed in order to optimize statistical power that ignored potential differences attributable to THM composition and quantitative estimates of exposure. We found that THM exposure did not perfectly classify the subjects DNA methylation levels (Supplementary Figure 1) . Limited sample size, exposure misclassification and individual unmeasured characteristics may explain these classification differences. Given that exposure was assigned based on residence, unaccounted socioeconomic factors (different to the educative level) might explain some of the observed differences.
36 DBPs and particularly THM as proxy of the whole mixture may behave differentially according to the specific route of exposure. Given the different molecular weights and polarity of the DBPs, potential exposure routes include not only ingestion but also inhalation and/or dermal absorption during showering and water related activities (cleaning, swimming, flushing the toilet, etc).
37-41 These routes, plus the subject water handling and consumption behaviors, may produce differential internal doses and explain partially why subjects apparently exposed equally to similar THM levels had a wide range of changes in DNA methylation levels in our sample. Exposure misclassification due to unaccounted non residential exposure (e.g. workplace) is expected to be low, only affecting the ingested THM fraction. On the other hand, individual DNA methyltransferases activity or specific protective genetic polymorphisms may enhance or reduce the epigenetic changes and reduce the potential for new DNA methylation changes. Unfortunately, we do not have data about this specific variables. 42, 43 Finally, as these processes may be perpetuated through inflammatory pathways, the role of chronic inflammation and its modification through anti-inflammatory medications (either intended or pleiotropic) is another potential target of future research in the area. 44 We used microarrays as a cost-effective approach to interrogate Epigenome wide DNA methylation changes associated with THM exposure. However, there are several analytical gaps in the Infinium HumanMethylation450K BeadChip analyses as there is no consensus for preprocessing and downstream analysis of the data. 45 We decided to be as conservative as possible and compared different approaches to observe internal reproducibility of results. The results were concordant using different approaches and we are confident that we tried to maximize our results while reducing potential analytical bias. This is the main strength of our study. In addition, the design was intended to maximize the power even under the small sample size constrain. In this first exploratory study with limited sample size and absence of experimental validation, we generate some hypotheses that require replication in new studies with larger sample size.
The use of whole blood samples instead of the target organ is a limitation in our study. As DNA methylation is time and organ specific we cannot assure that the differences found can be replicated on the target organs. Second, the cross sectional blood sampling does not allow us to observe the evolution of changes in time, as the samples were collected from a case-control study. However, there is a limited amount of longitudinal studies of cancer and to our knowledge none has evaluated THM exposure, being ours the first study to provide some potential hypotheses in humans about these mechanisms. Third, the changes found in methylation levels are relatively small (utmost 15%), which increases the probability of positive results by chance, even after adjusting for multiple comparison. Fourth, differentially methylated regions methods and pathway analyses for DNA methylation data are active and rapidly evolving research areas and results may differ by method applied. Our differentially methylated region results seem to be driven by the most differentially methylated probes, even if other probe differences were modest (absolute delta beta <0.01) or non-significant (FDR>0.05) in the differential methylation site analysis. Pathway analyses try to summarize common pathways assuming large gene-specific interactions included on curated databases but do not account for unknown intergenomic regions without annotated genes. In addition, without gene expression data, DNA methylation pathway analyses only may suggest but cannot provide exact information about the gene network underlying the observed methylation changes. Finally, we have not performed a laboratory validation using a different technique. This and the replication of the results are future steps that should be performed for confirmation. Thus we call for a cautious interpretation of the results given that some of them may be the product of chance.
In summary, our results suggest that long-term THM exposure affect DNA methylation in genes related to tumors including bladder and colorectal cancer among others. These findings, if confirmed or validated in other populations, may contribute to understanding the molecular mechanisms or THM pathogenesis.
MATERIALS AND METHODS

Study population
This study is part of a population-based case-control study of colorectal cancer, which in turn is part of a larger multicase-control study (MCC-Sp) conducted in Spain between 2007 and 2012. 46 A subset of population-based controls who provided a blood sample (81% among the recruited) were selected using a stratified random selection based on residence in Barcelona metropolitan area (four municipalities), age at recruitment (>60 years) and availability of lifetime estimates of THM levels (see below). Study subjects were frequency matched by age group (60-70 vs. 70-80 yrs) and THM levels (< vs. ≥ the median, 85µg/L). A total of 70 subjects (males and females) were selected in each exposure group (50% 60-70 years old, 50% 70-80 years old). The MCC-Sp project and the present study have been approved by the Investigation Review Boards of the different participant hospitals in Barcelona. All the participants had signed the informed consent of the main MCC study and agreed the molecular analyses.
Questionnaires
Trained interviewers administered a comprehensive computer assisted questionnaire to the study subjects in the primary care centers. Interview took around 90 minutes and included personal, socio-demographic, lifestyle, family history and medical history variables. A validated self-administered food frequency questionnaire was also filled in. The questionnaire is available at the study website: www.mccspain.org.
Lifetime trihalomethane exposure Exposure estimates were based on levels in the residence of the subject, as a proxy of exposure through all the routes (ingestion, inhalation, dermal contact) in different situations (drinking water and water-based fluids, showering, bathing, dish-washing, etc.). Residential history including complete address of all residences where study subjects had lived at least during one year since age 18 was requested. Trihalomethane levels in the study municipalities were estimated back to 1940 using available measurements. Historical data on water source and the available THM measurements were used to estimate annual average THM levels for years when measurements were absent. Available THM measurements were averaged and imputed to the past when water source and treatment were unchanged. Proportion of surface water was used as a weight to this average in the event of changes in water source. Before chlorination started, THM levels were assumed to be zero. Residential histories and estimated THM levels were merged by zip code and year to estimate average THM levels from age 18 to the time of interview in study subjects, according to previously published methodology. 47 Subjects included in this analysis had THM exposure data covering at least 70% of years from age 18 until the time of interview, with an average (range) of available data of 95.2% (74.1-100) of the years.
DNA extraction and Genome Wide DNA methylation array DNA was extracted from EDTA-treated blood using the Chemagic DNA Blood5k Kit (Perkin Elmer) following manufacturer's protocol at the Spanish National Genotyping Centre (CEGEN-Barcelona) and using a manual DNA extraction kit (PROMEGA) at the Bellvitge Biomedical Research Institute (IDIBELL). None of the samples presented visual signs of DNA degradation (smear bands or bands below 10,000 bp) as observed after running 100 ng of DNA on a 1.3% agarose gel. The isolated genomic DNA was stored at −80 °C until use. For every sample, 1µg of DNA was bisulfite converted using the Zymo EZ DNA methylation kit (ZYMO research corporation, Irvine, CA) according to manufacturer instructions. Converted DNA was eluted in 22µL of elution buffer. DNA methylation level was assessed using the Infinium HumanMethylation450K BeadChip (Illumina Inc., San Diego, CA, USA) 48 at the CEGEN facility at the Barcelona Biomedical Research Park (PRBB) according to manufacturer instructions (Infinium HD Assay Methylation Protocol Guide #part 15019519 Rev. A). Briefly, 4 µL of bisulfite-converted DNA was isothermally amplified overnight (20-24h) and fragmented enzymatically. DNA was precipitated using isopropanolol and collected after centrifugation at 4ºC. Precipitated DNA was resuspended in hybridization buffer and dispensed onto the Infinium HumanMethylation450K BeadChips using a robot (Tecan Group Ltd., Männedorf, Switzerland). Samples were distributed in random blocks according to inclusion criteria to reduce potential chip associated batch effects. Two samples were run by duplicate and one in triplicate, plus a Jurkat DNA control. In total, 12 chips were run (12 samples/chip). Every Infinium slide has 8 chips, thus two slides were run simultaneously in a single laboratory batch. The hybridization was performed at 48ºC overnight (16-20h) using an Illumina Hybridization oven (Illumina Inc., San Diego, CA, USA). The amplified and fragmented DNA samples anneal to locus specific 50mers (covalently link to some of the bead types) during hybridization. After hybridization, free DNA was washed away and the BeadChips were processed through a single nucleotide extension following immunohistochemistry staining (ddNTP) in capillary flow through chambers (Tecan GenePaint automated slide processor) using the Freedom Evo robot. Fluorescence signal was captured as an image on an Illumina iScan system using Illumina iScan software (Illumina Inc., San Diego, CA, USA). After background subtraction, two raw intensity data (idat) files were produced (one per channel) using Illumina GenomeStudio software.
Illumina 450K data preprocessing considerations The 450K array combines two assays in one platform: the Infinium I (type I probes) and Infinium II (type II probes). 48 The probes used to assess methylation levels are technically different. In consequence, preprocessing of 450K data should also control for potential differences between assays. In addition, two other technical biases are possible: probes that cross-hybridize, and probes mapping in polymorphic residues. 49, 50 Probes that cross-hibridize accounts for about 8.6% of the 450K array. Methylation levels measured in these probes likely reflect a combination of levels of methylation at the various locations to which these probes hybridize. On the other hand, polymorphic target probes (4.3% of 450K probes) are probes with polymorphisms at the target C or G at the extension point. Since the 450K platform quantitatively genotypes level of C/T SNPs after bisulfite conversion, these probes may assess a difference in genotype rather than a true difference in methylation levels.
Bioinformatic and Statistical analysis
The array data were preprocessed and then processed using R version 3.1.2 51 and different Bioconductor packages. 52 The pipeline used (adapted from RnBeads) 53 included the following steps: 1) loading raw intensity data (idat), 54 2) prefiltering (removal of SNP-enriched probes, greedycut algorithm removal of unreliable measurements, and removal of predefined blacklisted probes -all crossreactive probes and polymorphisms as reported by Chen et al. 50 ), 3) normalization (methylumi-noob for background correction 55 and dasen normalization 56 ), 4) quality control (detection and exclusion of technical failures during bisulfite conversion, hybridization, extension and staining, detection of potential sample mixups using the default 65 SNPs included in the array), 5) postfiltering (removal of non CpG probes, removal of sex chromosomes), 6) negative control batch effect correction 57 and surrogate variable analysis-sva multidimensional reduction adjusting for residual confounding, 7) visualization of the general unadjusted methylation profile. Once data were clean, the downstream data analysis was performed using beta values. The beta value (β) index was calculated using both intensities of DNA methylation fraction at a specific CpG site: β = M/(M + U + α) where M are methylated and U unmethylated signal intensities and α is an arbitrary offset (100) to stabilize β values whether the intensities are low. β values are bounded between 0 and 1.
58
Epigenome wide DNA methylation association analyses In total 144 samples were processed. From the original 140 study subjects, one was processed in duplicate and one in triplicate, and a Jurkat sample was added as a technical control. The duplicates correlation and triplicates correlation was between 0.995 and 0.998. One of the samples was selected at random to keep for further analyses. The other duplicates, the Jurkat sample and two mislabeled (cancer cases) were discarded, leaving 138 samples for analyses. We used an empirical Bayes moderated t-test and/or empirical Bayes moderated linear regression models using limma 57 to test the associations between THM levels and DNA methylation (measured as beta values). We selected some potential adjustment covariables: age, sex, municipality, highest education reached (elementary or less, high school, and university or more), and tobacco smoking (classified as never, former and current smokers). Using a surrogate variable approach, we detected a potential residual uncorrected batch effect and we included a surrogate variable in the adjusted models. 57 Finally, we used the Houseman algorithm (included in minfi) to estimate the proportions of white blood cells in our samples. In brief, this algorithm uses ~473 most informative CpG probes to estimate the proportions of T lymphocytes (CD8, CD4), Natural Killers-NK lymphocytes, B lymphocytes, monocytes and total granulocytes. Adjustment by cell mixtures control population cell stratification in the model due to specific cells populations DNA methylation epigenetic landmarks. 54, 59, 60 We used the selectModel option from limma to reduce multiple comparisons. This command compares nested models using the Akaike Information Criteria-AIC. Genomic inflation factor (lambda) 61 was calculated for adjusted and unadjusted models. Statistical significance after multiple testing comparison was established using the Benjamini-Hochberg false discovery rate-FDR. 62 Statistically significant differential methylation between groups was defined as an absolute deltabeta-|Δβ| ≥0.05. To define cut-offs, we defined the absolute observed delta beta as the difference between the average methylation of the comparison groups and the absolute expected deltabeta as the beta coefficient of the adjusted models. Finally, to capture differentially methylated regions we used DMRcate 63 , that uses the limma empirical Bayes t-moderated statistic calculated per probe and a Gaussian kernel smooth using a 1000 window. The estimate is smoothed based on the varying density of CpG sites given the irregular spacing of the data on the genome interrogated by the Infinium HumanMethylation450K BeadChip.
Pathway analyses Pathways associated with differentially methylated sites were interrogated using ConsensusPathDB and GSEA 64, 65 Three different approaches were used: 1) Overrepresentation analyses (number of overrepresented selected genes per set) 2) Gene Set Enrichment Analyses-GSEA using the KeGG and Reactome curated databases (full list of genes prerranked using the t-statistic of the adjusted model) and 3) Induced networks (induced relationships among genes-proteins filling the gaps of unmeasured products not represented/included on the differentially methylated list). 65, 66 For overrepresentation analyses, the background gene pool was limited to those genes annotated by Illumina in the array. A manual PubMed search of the top CpG sites was performed to annotate the genes associated with specific diseases/conditions. Sensitivity analyses We tested our preprocessing approach and modeling compared to other potential approaches to test reproducibility of the top hits. The following analyses were performed: beta values normalized using BMIQ, 67 a Genes were sorted by false discovery rate-FDR from the regression models adjusted for age, sex, the first principal component and the estimated white blood cell proportion. b The observed deltabeta corresponds to the mean difference of high exposed vs low exposed group to THM, confidence interval is based on a empirical Bayes moderated t-test. c The expected deltabeta corresponds to the beta coefficient of high exposed vs low exposed group to THM adjusted for age, sex, the first principal component and the estimated white blood cell proportion, confidence interval is based on a empirical Bayes moderated linear regression. d From PubMed search (gene expression, protein levels or genetic polymorphisms associated with specific molecular mechanisms or diseases in humans). CpG sites, which separates those subjects flagged as highly exposed in average to lifetime THM levels >85 µg/L (marked as black in the bottom box), from those exposed to lower levels (the remainder columns). In the right box each site is marked to its corresponding region. A scatterplot of the actual lifetime THM levels is shown at the bottom box.
β-values 24 Figure 3 . Network analysis of differentially methylated genes after adjustement by covariables Note: expected deltabeta (Δβ) is the methylation change expected after adjusting for age, sex, the first principal component and the estimated white blood cell proportion.
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Supplementary Figure S1 . Heatmap of the 140 top CpG sites (FDR<0.05) associated with THM exposure.
Note: DNA methylation heatmap of methylated genes passing FDR<0.05, in white blood cells DNA of persons exposed during lifetime to trihalomethanes. Each row represents a CpG site with columns representing each sample. The top dendrogram shows the results of an unsupervised hierarchical clustering of 138 samples based on 140 CpG sites, which separates those subjects flagged as highly exposed in average to lifetime THM levels >85 µg/L (marked as blue on top), from those exposed to lower levels (marked as red on top).
